Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?
{{output}}
Hematopoietic cell transplantation (HCT) is currently the only treatment with curative potential for patients with myelodysplastic syndrome (MDS). However, treatment-related mortality and relapse have remained major barriers to uniform success. Therefore, impo... ...
